New research being presented at the European Congress on Obesity (ECO 2025) has found that patients of an online obesity ...

The revolutionary GLP-1 class of weight loss drugs are racking up blockbuster sales at a pace rarely seen in the ...

David Kessler has lost more than 60 pounds on weight-loss drugs and believes they can change the trajectory of chronic ...

Separate study finds GLP-1 medicines combined with bariatric surgery may significantly reduce risk of serious cardiovascular ...

Ozempic for diabetes management is being widely talked about for its weight loss benefits. But it can also have side effects.

There may be improvement of AF-related outcomes in patients with type 2 diabetes, atrial fibrillation, and obesity treated with GLP-1RAs.

Semaglutide can rapidly reduce heart attacks and other serious cardiovascular complications in adults with overweight or obesity who have pre-existing cardiovascular disease but not diabetes, ...

The best metric is not weight, but a particularly toxic kind of fat.

Medications like semaglutide and liraglutide may help to reduce the risk for heart attacks, strokes, and other major adverse cardiovascular events (MACE) as well as death in adults with obesity and ...

Medications like semaglutide and liraglutide may help to reduce the risk for heart attacks, strokes, and other major adverse cardiovascular events ...

New data suggests the weight-loss drug Wegovy may significantly reduce the risk of heart disease even before users experience ...